Enterprise Sciences, Inc. — Department of Defense STTR Phase II: N10A-T043
Enterprise Sciences, Inc. — STTR Phase II award from Department of Defense.
- Amount
- $1,499,956
- Agency
- Department of Defense · Navy
- Program / Phase
- STTR · Phase II
- Topic
- N10A-T043
- Solicitation
- 2010.1
- NAICS
- —
- Place of performance
- MD
- Period
- 2011-07-14 → 2013-01-30
Description
Enterprise Sciences, Inc., and the University of Maryland School of Medicine have completed a Navy Phase I STTR feasibility and assessment study validating a new technology for portable devices that detect and monitor coagulopathy in traumatic injury and critically ill patients. This proposal is for a Phase II continuation of this work which will:Complete the validation of the technology with integrated breadboard blood sample testing from coagulopathic animal models; and produce an integrated One-of-Kind Alpha prototype demonstrating the ability to fabricate a rugged portable coagulopathy instrument